Drug Manufacturers
PE firm Advent International acquires 51% stake in ZCL Chemicals
Shelf life of vaccines likely to be more than 3 months, unlike drugs
Cipla posts net profit of Rs 665 cr in Q2, income from ops grows 15%
Govt revises PLI scheme for bulk drugs to boost local manufacturing
Revised, more industry-friendly PLI scheme for bulk drugs on the cards

As domestic sales decline, drug makers focus on exports to sustain growth
CVS raises profit forecast, in talks with US to administer Covid vaccines
Govt notifies incentive scheme for local API manufacturing to cut imports
Cipla to price Covid-19 drug remdesivir at less than Rs 5,000 per vial
Pvt players must help set up bulk drug, med devices pak: Mandaviya